GlaxoSmithKline plc (GSK) announced that Sir Christopher Gent and Sir Deryck Maughan are to join the board of the company as non-executive directors with effect from 1st June 2004.
It has also announced that Sir Christopher Hogg will retire from the board on 31st December 2004.
Sir Christopher Gent has been appointed deputy chairman and will succeed Sir Christopher Hogg as non-executive chairman with effect from 1st January 2005.
Commenting on the appointments, Sir Christopher Hogg, chairman of GSK said, "I am delighted that Chris and Deryck are joining the board.
Sir Christopher brings with him many years of experience and a track record of delivering outstanding performance in a highly competitive global industry which will be invaluable to GSK.